56.36000 USD
0.3856
0.69%
Last update Dec 17, 4:29 PM GMT
Main market
Day range
55.67000
57.84000
Previous close
55.97440
Open
56.25
Access this stock data via API
Subscribe
Crispr Therapeutics AG
56.36
0.39
0.69%

Financials

Income statement

Fundamentals currency is CAD
Fiscal date Aug 2022 May 2022 Feb 2022 Nov 2021
Total reported revenue 0 0 0 0
Cost of revenue 454 454 454 587
Gross profit -454 -454 -454 -587
Operating expense
Research & development
Selling general and admin 1.6M 2.3M 3.4M 1.2M
Other operating expenses 1.8M 126.2K 382.2K 17.3K
Operating income -3.4M -2.4M -3.8M -1.2M
Non operating interest income
Income
Expense 978 6.2K 233.1K 18.3K
Other income expense -179.5K 3.4M -1.8M -4.0M
Pretax income -3.6M 974.7K -5.9M -5.3M
Tax provision
Net income -3.6M 974.7K -5.9M -5.3M
Basic EPS 0.0 0.0 0.0
Diluted EPS 0.0 0.0 0.0
Basic average shares 275.9M 261.9M 255.2M
Diluted average shares 275.9M 261.9M 255.2M
EBITDA -4.4M -3.4M -5.4M -1.9M
Net income from continuing op. -3.6M 974.7K -5.9M -5.3M
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 2 hours 45 minutes

13:44
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).